Wesbanco Bank Inc Dexcom Inc Transaction History

Wesbanco Bank Inc

  • $2.89 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 18, 2023
BUY
$84.98 - $122.67 $1.5 Million - $2.16 Million
17,617 New
17,617 $2 Million
Q2 2022

Jul 18, 2022
BUY
$67.99 - $132.89 $538,140 - $1.05 Million
7,915 Added 300.95%
10,545 $786,000
Q1 2022

Apr 25, 2022
BUY
$94.08 - $130.2 $247,430 - $342,425
2,630 New
2,630 $1.35 Million

Others Institutions Holding DXCM

# of Institutions
1,016
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Wesbanco Bank Inc Portfolio

Follow Wesbanco Bank Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wesbanco Bank Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wesbanco Bank Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email